Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/20/2021
Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...
12/20/2021
MOF: China To Lower Import Tariffs on 954 Products in 2022
12/20/2021
Novartis Granted Chinese Approval of Its Anti-CD20 Antibody Ofatumumab...
12/20/2021
Xpovio Combo Conditionally Approved in China for Repeatedly Treated rr...
12/20/2021
Cytokinetics and Ji Xing Expand Collaboration for Omecamtiv Mecarbil i...
12/17/2021
CBMG Cleared of U.S. IND of Bi-Specific CAR-T Cell Therapy C-CAR039...
12/17/2021
BioMarin and Skyline Therapeutics in Deal to Co-develop Novel Gene The...
12/17/2021
IQVIA: Chinese Retail Pharmacy Sales Up Only 0.3% in Q3/2021
12/17/2021
Review of Retail Pharmacy Sales of VBP Prevailing and Failure Drug Pro...
12/17/2021
Recent Executive Moves
12/16/2021
US Sanctions Chinese Painkiller Makers Amid Addiction Epidemic, As Sen...
12/16/2021
Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...
12/16/2021
US Sanctions Chinese Tech Firms/Institutes for Weaponizing Biotech, Sp...
12/15/2021
China Biopharma, Tech Stocks Fall on Reports of Expanded U.S. Sanction...
12/15/2021
New Study: China Healthcare under Remaking in Digital Era
12/15/2021
Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom (WSJ)
12/14/2021
Antengene Enters Clinical Collaboration with BMS to Evaluate ATG-017 i...
12/14/2021
China Issues the Provisions for National Pharmaceutical Reserve (2021 ...
12/13/2021
IQVIA: Chinese Hospital Drug Market Growth Slowed to 2.7% in Q3/2021
12/13/2021
Universe and Kitanihon Enter Strategic Deal with Plan for Kampo Man...
12/13/2021
Biosion Licenses Worldwide Rights of Anti-TROP-2 mAb BSI04702 to OBI P...
12/13/2021
CDE: Annual Report on Clinical Trials for New Drug Registration in Chi...
12/13/2021
China's NRDL Explained: 67 New Drugs, 62% Price Cut, 80% Success Rate ...
12/13/2021
Nine Observations from A Busy Few Weeks Back at the Heart of the China...
12/10/2021
Recent Executive Moves
12/9/2021
Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to...
12/9/2021
Simcere Pharma and Immunophage Gain Three New Drug IND Approvals in Ch...
12/9/2021
China Extends Crackdown of BMI Frauds for Another Year
12/8/2021
CDE Issues the Technical Guidelines for Application of Biomarkers in C...
12/8/2021
Shanghai Pharma and Syntegon Partner to Promote Continuous Manufacturi...
Page:
75
/
356
Total number of articles:
10680
:
[First]
[<<]
[73]
[74]
[75]
[76]
[77]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit